T2DM pathogenesis typically sees a steady decline in pancreatic β-cell function resulting in lower levels of insulin secretion which is concurrent with an increase in insulin resistance in adipocytes, hepatocytes and skeletal muscle(5). The gene discussed is INS; the disease is type 2 diabetes mellitus.